MicroRNA-219 in the central nervous system: a potential theranostic approach
Nahal Shamaeizadeh, Mina Mirian · 2024
Read MicroRNA-219 in the central nervous system: a potential theranostic approach by Nahal Shamaeizadeh, Mina Mirian (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11792714.txt.
Description
Nahal Shamaeizadeh and Mina Mirian review a small brain RNA as a drug and diagnosis candidate in a paper from two thousand twenty-four. MicroRNAs tune gene activity by binding to messenger RNAs. One of them, microRNA-219, is rich in the brain and shapes nerve cell growth.
The molecule helps sheath-making cells mature and repair myelin, the insulation around nerve fibers. That makes it a candidate for multiple sclerosis and spinal cord injury. It also steers the body clock, touches mood stability, and curbs tau harm seen in Alzheimer's disease. Reports add protection against seizures and Parkinson's disease, plus anti-tumor effects. The authors map its pathways for future gene therapy.
Catalog record
| CREATOR | Nahal Shamaeizadeh, Mina Mirian |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |